151 related articles for article (PubMed ID: 35008339)
1. Preoperative Nodal US Features for Predicting Recurrence in N1b Papillary Thyroid Carcinoma.
Eun NL; Kim JA; Gweon HM; Youk JH; Son EJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008339
[TBL] [Abstract][Full Text] [Related]
2. PROGNOSTIC VALUE OF LYMPH NODE UPTAKE ON PRETREATMENT F-18 FDG PET/CT IN PATIENTS WITH N1B PAPILLARY THYROID CARCINOMA.
Lee CH; Lee SW; Son SH; Hong CM; Jeong JH; Jeong SY; Ahn BC; Lee J
Endocr Pract; 2019 Aug; 25(8):787-793. PubMed ID: 31013158
[No Abstract] [Full Text] [Related]
3. Identifying risk factors for recurrence of papillary thyroid cancer in patients who underwent modified radical neck dissection.
Ryu YJ; Cho JS; Yoon JH; Park MH
World J Surg Oncol; 2018 Oct; 16(1):205. PubMed ID: 30314503
[TBL] [Abstract][Full Text] [Related]
4. Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma.
Kim SY; Kwak JY; Kim EK; Yoon JH; Moon HJ
Radiology; 2015 Nov; 277(2):574-83. PubMed ID: 25955580
[TBL] [Abstract][Full Text] [Related]
5. Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.
Kang IK; Kim K; Park J; Bae JS; Kim JS
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954338
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
Lee SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg; 2019 May; 269(5):966-971. PubMed ID: 29462007
[TBL] [Abstract][Full Text] [Related]
7. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2012 Mar; 36(3):593-7. PubMed ID: 22207493
[TBL] [Abstract][Full Text] [Related]
8. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
Wu Y; Li J; Wu X; Dai L
Curr Pharm Des; 2018; 24(5):559-563. PubMed ID: 28990528
[TBL] [Abstract][Full Text] [Related]
9. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Dec; 97(51):e13435. PubMed ID: 30572443
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
[TBL] [Abstract][Full Text] [Related]
11. Cystic Lateral Lymph Node Metastases From Papillary Thyroid Cancer Patients.
Kim JK; Kim MJ; Choi SH; Choi SM; Choi HR; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Laryngoscope; 2020 Dec; 130(12):E976-E981. PubMed ID: 32275332
[TBL] [Abstract][Full Text] [Related]
12. Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.
Zheng CM; Ji YB; Song CM; Ge MH; Tae K
Clin Exp Otorhinolaryngol; 2018 Mar; 11(1):58-64. PubMed ID: 29032663
[TBL] [Abstract][Full Text] [Related]
13. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
Kim HI; Kim TH; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim YN; Kim H; Ahn HS; Kim K; Kim SW; Chung JH
Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
[TBL] [Abstract][Full Text] [Related]
14. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
15. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.
Wang LY; Palmer FL; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I
Ann Surg Oncol; 2015 Oct; 22(11):3530-6. PubMed ID: 25665952
[TBL] [Abstract][Full Text] [Related]
16. Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
Lee SG; Ho J; Choi JB; Kim TH; Kim MJ; Ban EJ; Lee CR; Kang SW; Jeong JJ; Nam KH; Jung SG; Jo YS; Lee J; Chung WY
Medicine (Baltimore); 2016 Feb; 95(5):e2692. PubMed ID: 26844509
[TBL] [Abstract][Full Text] [Related]
17. Patterns, Predictive Factors, and Prognostic Impact of Contralateral Lateral Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma.
Kim SK; Park I; Hur N; Rayzah M; Lee JH; Choe JH; Kim JH; Kim JS
Ann Surg Oncol; 2017 Jul; 24(7):1943-1950. PubMed ID: 28160142
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Lateral Neck Recurrence of N0/N1a Papillary Thyroid Cancer.
Kim Y; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2017 Nov; 24(12):3609-3616. PubMed ID: 28822118
[TBL] [Abstract][Full Text] [Related]
20. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
